Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction-Reference-Cited by-同舟云学术

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

Published:2015-07-28 Issue:38 Volume:36 Page:2585-2594
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

González-López Esther,Gallego-Delgado Maria,Guzzo-Merello Gonzalo,de Haro-del Moral F. Javier,Cobo-Marcos Marta,Robles Carolina,Bornstein Belén,Salas Clara,Lara-Pezzi Enrique,Alonso-Pulpon Luis,Garcia-Pavia Pablo

Funder

Pfizer Inc

Investigator Initiated Research Grant

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/36/38/2585/17154658/ehv338.pdf

Reference36 articles.

1. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

2. Heart failure with preserved ejection fraction: a clinical dilemma

3. Developing Therapies for Heart Failure With Preserved Ejection Fraction

4. New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes

5. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study

Cited by 868 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of cardiac conduction disease in patients with cardiac amyloidosis: A national retrospective cohort study;International Journal of Cardiology;2024-12

2. Is It Time for Population-Based Screening for Transthyretin Cardiac Amyloidosis?;JACC: Advances;2024-10

3. The Mayo ATTR‐CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis;European Journal of Heart Failure;2024-09-09

4. International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction;Amyloid;2024-09-08

5. Clinical Update in Heart Failure with Preserved Ejection Fraction;Current Heart Failure Reports;2024-09-03